The RECHORD trial allows cardiovascular surgeons to replace damaged string-like tendons, called chordae, through a small incision while the heart is beating. The trial compares outcomes from this minimally invasive procedure to traditional open-heart mitral valve surgery, which requires the chest to be cracked. Specialized imaging is used to place the artificial chordae. PinnacleHealth is one of only 20 sites in the nation and the only hospital in Pennsylvania selected to participate in the trial. Up to 450 patients will be enrolled into the randomized trial.

January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ...

January 5, 2017 — A new report published by Allied Market Research forecasts that the global thrombectomy devices market ...

January 5, 2017 – Reacting to a critical shortage of electrophysiology (EP) lab technicians and nurses who treat heart ...

January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditation ...

In a study published online by JAMA Cardiology, researchers from Stanford University assessed the feasibility of measuring physical activity, fitness and sleep from smartphones. The goal was to gain insight into activity patterns associated with life satisfaction and self-reported disease.

A new minimally invasive technique for repairing the most common cardiac birth defect in extremely premature newborns can be performed safely with a high success rate in babies as small as 755 grams – about 1.6 pounds – only a few days after birth.

January 4, 2017 — A new ground-breaking technology that allows evaluation of cardiac valves using holograms was ...